Zhaoke Ophthalmology Pharmaceutical Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zhaoke Ophthalmology Pharmaceutical Ltd.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- China Ophthalmology Focus Limited (COPFL)